A Novel 5-HT1B Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer's Disease
The serotonin receptor 5-HT1B is widely expressed in the central nervous system and has been considered a drug target in a variety of cognitive and psychiatric disorders. The anti-inflammatory effects of 5-HT1B agonists may present a promising approach for Alzheimer's disease (AD) treatment. He...
Saved in:
Main Authors: | Yang Yang (Author), Lijing Zhang (Author), Jiaojiao Yu (Author), Zhaobin Ma (Author), Moxiang Li (Author), Jin Wang (Author), Pengcheng Hu (Author), Jia Zou (Author), Xueying Liu (Author), Ying Liu (Author), Su An (Author), Cheng Xiang (Author), Xiaoxi Guo (Author), Qian Hao (Author), Tian-Rui Xu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-PTSD Effects of Hypidone Hydrochloride (YL-0919): A Novel Combined Selective 5-HT Reuptake Inhibitor/5-HT1A Receptor Partial Agonist/5-HT6 Receptor Full Agonist
by: Wen-Gang Liu, et al.
Published: (2021) -
Contribution of Active and Inactive States of the Human 5-HT4d Receptor to the Functional Activities of 5-HT4-Receptor Agonists
by: Tadayoshi Mikami, et al.
Published: (2008) -
Effects of (−)‐MBP, a novel 5‐HT2C agonist and 5‐HT2A/2B antagonist/inverse agonist on brain activity: A phMRI study on awake mice
by: Preeti K. Sathe, et al.
Published: (2023) -
Quantitative proteomic analysis reveals the effects of mu opioid agonists on HT22 cells
by: Xutong Zhang, et al.
Published: (2023) -
Cost analysis of migraine pharmacotherapy with selective 5HT1 receptor agonists in Ukraine
by: Yaryna Hrynkiv, et al.
Published: (2021)